Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Environmental Pollution
- Vol. 225, 261-269
Abstract
No abstract availableKeywords
Funding Information
- EU Commission
- German Federal Ministry for Education and Research (02WRS1275I)
- Water JPI project Frame (02WU1345A)
This publication has 33 references indexed in Scilit:
- lazar: a modular predictive toxicology frameworkFrontiers in Pharmacology, 2013
- Pharmacokinetics of the Monohydroxy Derivative of Oxcarbazepine and Its Enantiomers after a Single Intravenous Dose Given as Racemate Compared with a Single Oral Dose of OxcarbazepineDrug Metabolism and Disposition, 2011
- Transformation of the antiepileptic drug oxcarbazepine upon different water disinfection processesWater Research, 2011
- Transformation Products in the Life Cycle Impact Assessment of ChemicalsEnvironmental Science & Technology, 2010
- Pharmaceutical metabolites in the environment: Analytical challenges and ecological risksEnvironmental Toxicology and Chemistry, 2009
- QSAR Prediction of Estrogen Activity for a Large Set of Diverse Chemicals under the Guidance of OECD PrinciplesChemical Research in Toxicology, 2006
- Peer Reviewed: When Synthetic Chemicals Degrade in the Environment2004
- Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?Water Research, 2003
- Oxcarbazepine, an antiepileptic agentClinical Therapeutics, 2001
- Occurrence of drugs in German sewage treatment plants and riversWater Research, 1998